Andrew J. Roth
Advertisement
Articles by Andrew J. Roth
European Cancer Congress 2013
Advertisement
Latest Updated Articles
- Pooled Analysis Reinforces Long-Term Survival Benefit With Ipilimumab
Published: October 23rd 2013 | Updated:
- Reversing Halt, FDA Reauthorizes Sale of Ponatinib
Published: February 12th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Show Most CRS, ICANS Cases Happen Within 15 Days of Liso-Cel Infusion
2
Real-World Usage of Nintedanib for PPF Differs From Trial Settings
3
Long-Term Adalimumab Improves Work, Life Quality in Psoriasis
4
From Trial Diversity to Telehealth: Advancing Equity and Access in Rural and Underserved Cancer Care
5
